Impact of biological/targeted versus conventional synthetic disease‐modifying antirheumatic drugs on patient‐reported outcomes in rheumatoid arthritis

Abstract Background In patients with rheumatoid arthritis (RA), patient‐reported outcomes (PROs) may vary by disease‐modifying antirheumatic drug (DMARD) class. This study aimed to assess the impact of biological/targeted synthetic DMARDs (b/tsDMARDs) on PROs in patients with sustained low RA activi...

Full description

Bibliographic Details

Main Authors:	Masafumi Sugiyama, Saki Okuda‐Tsuchimoto, Takashi Tsuchimoto, Koji Kinoshita, Itaru Matsumura
Format:	Artigo
Language:	Inglês
Published:	Wiley 2026-06-01
Series:	Rheumatology & Autoimmunity
Subjects:	b/tsDMARDs methotrexate patient‐reported outcomes rheumatoid arthritis
Online Access:	https://doi.org/10.1002/rai2.70048
Tags:	Add Tag No Tags, Be the first to tag this record!